anti-SARS-CoV-2 equine antibody fragments F2 (VINS BioProducts)

N/A

Report date: 2025/01/26 19:31:49

Base Information

Drug Nameanti-SARS-CoV-2 equine antibody fragments F2 (VINS BioProducts)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Polyclonal antibodiesBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment
Mechanisms of ActionImmunoglobulin agonists
TargetsImmunoglobulin
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Pneumonia, Viral
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVins Bioproducts Limited
China Registration ClassN/A

Develop Information

Active CompaniesVins Bioproducts Limited
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Pneumonia, Viral
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A